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NLPorporation of membrane proteins into discoidal nanolipoprotein particles (NLPs)
we have used atomic force microscopy (AFM) to image and analyze NLPs assembled in the presence of
bacteriorhodopsin (bR), lipoprotein E4 n-terminal 22k fragment scaffold and DMPC lipid. The self-assembly
process produced two distinct NLP populations: those containing inserted bR (bR-NLPs) and those that did not
(empty-NLPs). The bR-NLPs were distinguishable from empty-NLPs by an average increase in height of 1.0 nm
asmeasured byAFM. Streptavidin binding to biotinylated bR conﬁrmed that the original 1.0 nmheight increase
corresponds to br-NLP incorporation. AFM and ion mobility spectrometry (IMS) measurements suggest that
NLP size did not vary around a single mean but instead there were several subpopulations, which were
separated bydiscrete diameters. Interestingly, when bRwas present during assembly the diameter distribution
was shifted to larger particles and the larger particles had a greater likelihood of containing bR than smaller
particles, suggesting that membrane proteins alter the mechanism of NLP assembly.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionApproximately one third of all eukaryotic proteins are membrane
associated. These membrane proteins are involved in numerous vital
biological processes including signal transduction, transport, adhesion,
and cell–cell communication, and are the primary targets of many
therapeutic drugs [1,2]. Despite the recognized importanceofmembrane
proteins, few robust and versatile methods exist for the isolation and
solubilization of these biological molecules in their properly folded and
functional state. Self-assembling nanolipoprotein particles (NLPs) have
been identiﬁed asa potentialmembranemimetic for the solubilization of
membrane proteins. Puriﬁed apolipoproteins and phospholipids are
known to self-assemble in vitro to form nano-scale discoidal bilayer
patches orNLPs,where the lipoproteins localize to theNLPperimeter [3–
6]. Recently, it has been shown that when membrane proteins are
present during the NLP self-assembly process, the membrane protein
will associate with NLP constructs producing soluble and functional
integral membrane protein complexes [7–17]. The ability to incorporate
membrane proteins into the bilayer environment contained within the
NLP offers both scientiﬁc and technological promise.tacted at Chemistry, Materials,
aboratory, 7000 East Avenue,
8; fax: +1 925 422 2282. T.A.
echanical Engineering, MRDC
), todd.sulchek@me.gatech.edu
ll rights reserved.Although several groups have reported successful incorporation of
membrane proteins into NLPs, their collective focus has been on
characterization by PAGE analysis and functional assessment; quantiﬁca-
tion of overall yield and incorporation efﬁciency has largely been ignored.
However, it will likely be important to understand and controlmembrane
protein incorporation efﬁciencies and NLP heterogeneity in order to
maximize the utility of NLPs for the study of membrane proteins.
Biochemical techniques alongwith single particle analyses can offer
powerful insights into NLP size polydispersity [18–21] that may play an
important role in understanding membrane protein incorporation. For
example, atomic force microscopy (AFM) imaging, in principle, can
directly verify incorporation of membrane proteins into individual
NLPs, since the particle height resolution is sufﬁcient to distinguish the
topographic height change resulting from a membrane protein
extending above the face of the phospholipid bilayer. Here, we use
AFM to study bacteriorhodopsin incorporation into NLPs assembled
from the phospholipid 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine
(DMPC) and a fragment from the human apolipoprotein E4 (apoE422K).
2. Materials and methods
2.1. Materials
Phospholipid 1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine
(DMPC) was purchased from Avanti Polar Lipids, Inc. (Alabaster, AL).
Bacteriorhodopsin was purchased from Sigma-Aldrich (St. Louis, MO).
725C.D. Blanchette et al. / Biochimica et Biophysica Acta 1788 (2009) 724–7312.2. apoE422k protein production
The expression clone to produce apoE422k, the N-terminal 22 kDa
fragment of apolipoprotein E4 (apoE4), as a 6-His and thioredoxin
tagged construct was kindly provided by Dr. Karl Weisgraber.
Production and puriﬁcation of apoE422k have been described in
detail elsewhere [6].
2.3. Nanolipoprotein particle (NLP) formation
bR-NLPs were assembled through a process adapted from the
detergent dialysis technique [19]. The ﬁnal concentration of detergent
was above the critical micellar concentration. Sodium cholate
(20 mM) was prepared from a 500 mM stock solution and added to
DMPC suspended in Tris buffered saline to a concentration of 34 mg/
ml and probe sonicated to clarity. The solutionwas brieﬂy centrifuged
to remove any metal contamination from the probe. Constituents
were combined at the following concentrations; DMPC, 11 mM:
apoE422k, 90.9 μM: bR, 49.8 μM; creating a molar ratio of 130:1:1.83
respectively. “Empty” NLPs (without bR) were assembled as described
previously [6].
NLP assembly started with three repeated sets of transition
temperature incubations, where the temperature was cycled from
30 °C for 10 min to 20 °C for 10 min, with gentle agitation between
incubations. The reaction was incubated overnight at 23.8 °C. Cholate
was removed by dialysis against 1000× volume of 10 mM Tris pH 7.4,
0.15 M sodium chloride, 0.25 mM EDTA, 0.005% sodium azide (TBS)
buffer with 3 changes in 24 h. The NLPs were puriﬁed from free
protein and free lipid by size-exclusion chromatography (VP HPLC,
Shimadzu) using a Superdex 200 HR 10/30 column (GE Healthcare), in
TBS at a ﬂow rate of 0.5 ml/min. The column was calibrated with four
protein standards of known molecular weight and Stokes diameter
that span the separation range of the column and the NLP samples.
The void volume was established with Blue dextran. Two fractions
containing br-NLPs were concentrated to approximately 0.1 mg/ml
using molecular weight sieve ﬁlters (Vivascience) with molecular
weight cutoffs of 50 kDa. Protein concentrationwas determined using
the ADV01 protein concentration kit (Cytoskeleton, Inc., Denver).
2.4. Fluorescent labeling
Cy3 and Cy2 were conjugated to the E422K scaffold and bR,
respectively, using the Cy3/2 Ab Labeling Kit (GE Healthcare Life
Sciences, Piscataway, NJ) as described in the manufacturer's instruc-
tions. Dye:protein ratios were determined by comparing the absor-
bance of the protein at 280 nm and the absorbance of the Cy dye at
670 nm and 532 nm respectively. In both cases, the ratios provided a
1:1 correlation, suggesting that on average a single Cy dye molecule is
present on each protein.
2.5. Biotinylation
Bacteriorhodopsin in membrane sheets (Sigma) was selectively
Biotinylated at solvent exposed lysines and primary amines using EZ-
Link Sulfo-NHS-LC-Biotin (Pierce Chemical Co., Rockford, IL). There are
6 lysine residues and N terminal groups on the exposed cytosolic
extracellular domains of bR. bR was resuspended in BupH PBS buffer
pH 7.4 (Pierce). A freshly made 10 mM solution of EZ-Link Sulfo-NHS-
LC-Biotin (Pierce) was prepared according to the manufactures
recommendation in double-deionized H2O (ddH2O), added to the bR
in a 20-fold molar excess and incubated on ice for 2 h. Excess biotin
was removed by 3 repeated centrifugation steps in an ultracentrifuge
at an 89,000 RCF for 20 min at 4 °C. The biotin labeled bR pellet was
resuspended in TBS buffer. The percent recovery, by UV–visible
spectroscopy, was determined to be 85–90% on average with careful
re-suspension.2.6. Microarray streptavidin binding
Proteins were spotted on GAPSII amino silane glass slides (Corning
Life Sciences Inc., Corning, NY) in 4 ·4 squares with 16 replicates of
each sample, generating ∼300 μm diameter spots with a spot-to-spot
distance of ∼350 μm. All samples were spotted (10 nl) using a robotic
system. Non-biotinylated bR and “empty”-NLPs served as the negative
controls, and biotinylated bR served as the positive control. All
samples containing bacteriorhodopsin had concentrations of 10 mM
bR as determined by UV/vis spectroscopy, the NLP protein concentra-
tion without bR (“empty”-NLP) was 1.5 mg/ml. Proteins were cross-
linked to the glass slides upon exposure to UV light for 5 min. An
applied hybridization chamber (Grace Bio-labs, Bend, OR) was used
for the blocking, washing and binding steps, with a volume capacity of
950 μl. Slides were blocked with BSA (1mg/ml) for 30min. Slides were
washed with 1× PBS for 15 min followed by cyanine-5-streptavidin
(Rockland Immunochemicals, Inc., Philadelphia, PA) binding (5 μg/ml)
for 15 min. Subsequent washes were in 1× PBS and ddH2O water each
for 15 min. Slides were then dried by centrifugation. Cyanine 5-
Streptavidin ﬂuorescence in a ScanArray 5000 XL; PerkinElmer
Proteins and NLPs were detected and imaged with a laser-based
confocal scanner (ScanArray 5000 XL; PerkinElmer) using the VHeNe
594 nm laser for excitation of Cy5-labeled streptavidin. Images were
collected and mean pixel intensities were analyzed using Scan Array
software (Perkin Elmer Life and Analytical Sciences Inc., Waltham,
MA).
2.7. Streptavidin binding for AFM
Streptavidin (SA) molecules (Sigma) were incubated with biotin-
bR assembled NLPs (bio-br-NLPs) at a 2:1 molar ratio for 30 min and
unbound SA was removed by ﬁltering using molecular weight sieve
ﬁlters (Vivascience) with molecular weight cutoffs of 100 kDa. The
resultant particles were imaged by AFM.
2.8. Native PAGE
Equal amounts of NLP samples (0.5–2 μg) were diluted with 2×
native sample buffer (Invitrogen Corps., Madison WI) and loaded
onto 4–20% gradient pre-made Tris–HCl gels (Invitrogen). Samples
were electrophoresed for 250 V h at a constant 125 V. After
electrophoresis, gels were incubated with Sypro Ruby for 2 h and
then destained using 10% MeOH and 7% Acetic acid. Following a brief
wash with ddH2O, gels were imaged using a Typhoon 9410 (GE
Healthcare) at 532 nm (green laser) with a 610 nm bandpass 30 ﬁlter.
Molecular weights were determined by comparing migration vs. log
molecular weight of standard proteins found in the NativeMark
standard (Invitrogen). The Stokes diameter of the NLPs was calculated
from the known Stokes diameter of the same proteins in the standard
sample.
2.9. SDS PAGE
Protein fractions were analyzed by SDS-PAGE gels, stained with
Sypro Ruby (BioRad Laboratories, Inc., Hercules, CA) and ﬂuores-
cently imaged with a Typhooon 9410 (GE Healthcare), as described
above.
2.10. UV–visible spectroscopy
UV–visible spectra were collected using 50 μl of sample in a
quartz cuvette on an ultrospec 5300pro UV/visible spectrophot-
ometer (GE Healthcare) Dark adapted spectra were collected after
keeping the sample wrapped in foil overnight. Light adapted spectra
were collected after exposure to full spectrum bright light for
15 min.
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Atomically ﬂat Muscovite mica disks were glued to metal
substrates to secure them to the scanner of a stand-alone MFP-3D
AFM (Asylum Research, Santa Barbara, CA). 2 μl of the NLP solution at a
100 ng/ml concentration was incubated for 2 min on the mica surface
in imaging buffer (10 mM MgCl2, 10 mM Tris–HCL, and 0.1 M NaCl,
adjusted to pH 8.0) then lightly rinsed. The AFM has a closed loop in
the x, y, and z axes, which improved imaging ﬁdelity. The
topographical images were obtained with oxide sharpened silicon
nitride levers (MSCT, Veeco, Santa Barbara, CA) with a spring constant
of 0.1 N/m. Images were taken in alternate contact (AC) mode, also
known as tappingmode, in an aqueous environment, with amplitudes
below 20 nm and an amplitude setpoint at 65% of the tapping
amplitude, scan rates were below 1.5 Hz. Height, amplitude, and phase
images were recorded. High resolution 600 nm by 600 nm images
were acquired at 512 by 512 pixel resolution, such that each NLP on
average contained 600 pixels. The density of particles on the mica
substrate was kept low, on average 90 particles per 1 μm2, to facilitate
individual particle identiﬁcation and sizing. Experiments were carried
out in a temperature controlled room at 23±1 °C, with acoustic hood
isolation and active vibration damping.
2.12. AFM image analysis
The height of features in the images were examined by histogram
analysis using IgorPro Wavemetrics software routines, where con-
tiguous particles were deﬁned by a threshold height above the
background and the height arbitrarily deﬁned as the maximum height
contained by 10 or more pixels within the particle. Particle diameter
was determined by the full width half maximum (FWHM) analysis of
contiguous particles in the slow scan direction (vertical), using IgorPro
Wavemetrics software routines. In addition, to limit instrument
broadening during lateral particle sizing, only tips revealing sharp
imaging were used for diameter analysis. We have previously
determined, based on NLP size and MD simulations, that the average
tip broadening effect was ∼2–3 nm [21]. To determine theFig. 1. (A) bR-NLP assembly protocol. The reagents undergo a temperature transition and det
NLP assembly monitored at absorbance of 280 nm. The SEC proﬁle post NLP assembly conta
NLP rich peak, apoE422k rich peak and bR rich peak.reproducibility of the procedure used for measuring NLP diameters,
randomly selected particles were repeatedly imaged to verify
consistent diameter measurements. To remove image slopes and
offsets, raw AFM images were ﬂattened with a planar ﬁt using Asylum
Research data modiﬁcation routines. To avoid coupling the NLP into
the ﬂattening procedure, surface features higher than 1 nm were
masked followed by a second round of ﬂattening. This procedure
produced a ﬂat mica surface while not altering the NLP height.
2.13. Ion mobility spectrometry
IMS determines the mean aerodynamic diameter population
distribution of particles in a volatile buffer. NLP samples were
exchanged via dialysis into a 25 mM ammonium acetate buffer and
the aerodynamic diameter of NLPs were determined with a Macroion
Mobility Spectrometer (Model 3890, TSI Inc., Shoreview, MN), as
previously described [22,23]. NLP aerodynamic diameters were
subsequently converted to aerodynamic spherical volumes as pre-
viously described [21].
3. Results
3.1. NLP assembly, SEC puriﬁcation, native gel electrophoresis, SDS-PAGE
analysis and UV–visible spectroscopy
Following assembly (Fig. 1A), NLPs were separated from other
assembly components using SEC (Fig. 1B). The SEC proﬁle contained
four dominant peaks, a lipid rich peak, an NLP rich peak, apoE422k
rich peak and bR rich peak (Fig. 1B). The NLPs from assemblies both in
the absence and presence of bR were subjected to native-PAGE and
SDS-PAGE electrophoresis (Fig. 2A and B). Bands on the native gel from
the bR containing assemblies spanned the molecular weight range of
300–950 kDa, indicating the sample was highly heterogeneous. Single
bands at ∼22 kDa and ∼21.5 kDa were observed by SDS-PAGE for
empty NLP assemblies (lanes 2) and bR alone (lane 3), respectively
(Fig. 2B). In contrast, NLPs assembled in the presence of bR (bR-NLP
assembly—lane 4) contained two bands by SDS-PAGE at ∼22 kDa andergent dialysis to self assemble the NLPs. (B) SEC chromatography puriﬁcation after bR-
ined four dominant peaks corresponding to (from left to right) a free lipid rich peak, an
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NLP constructs (Fig. 2B).
Native gels and SDS gels of SEC fractions from ﬂuorescent
assemblies were also imaged with a ﬂuorescent scanner. Fluorescent
scans of the native gel indicated that Cy3-E422k (red) and Cy2-bR
(green) were in the same band (pseudo colored yellow) for SEC
fractions spanning the entire NLP rich peak, again in the molecular
weight range of 300–900 kDa (Fig. 2C). These results suggest that
these two proteins are co-localized within the NLP constructs. Cy3-
apoE422k and Cy2-bR bands were also observed by SDS-PAGE for bR-
NLP assemblies in the SEC fractions that spanned the entire NLP rich
peak. Interestingly, early eluting fractions (lane 4) appeared to contain
a higher concentration of Cy2-bR relative to Cy3-apoE422k (Fig. 2D).
To assess the functional state of bacteriorhodopsin after br-NLP
assembly UV–visible spectroscopy of light- and dark-adapted br-NLPs
was conducted. A 6 nm red-shift between the dark and light adapted
spectra, from 550.7 nm to 556.0 nm peak, was observed by this
technique (Fig. 2E). This shift indicates a properly folded protein
structure [24]. In addition, the NLP solution was purple indicating
bound retinal (data not shown).Fig. 2.Native gel, SDS PAGE and UV—visible spectroscopy of bR-NLPs. (A) Native gel electorpho
NLP assembly, bR, and bR-NLP assembly. The bR-NLP lane displays two distinct bands correspo
entireNLP-rich peak for bR-NLPs assembled fromcy2 labeled bR and cy3 labeled apoE422k,w
of both proteins. In themarker lane the 480 kDa and 720 kDaMWbandswere based on a sypro
SEC fractions spanning the entire NLP-rich peak for bR-NLPs assembled from Cy2-bR and C
indicating the presence of both cy2-bR and cy3-apoE422k. E) UV–vis absorbance spectra sh
adapted bR NLPs respectively. Empty NLPs showed no signiﬁcant absorbance at these wavel3.2. Atomic Force Microscopy (AFM) and Ion mobility spectrometry (IMS)
analysis of NLPs
Fig. 3A shows a typical 600 nm×600 nm AFM image of NLPs from a
bR-NLP assembly that have been adsorbed onto a mica surface; the
inset provides a more detailed perspective of two NLPs. AFM images
were pseudo colored where red represents themica surface and green
represents the tops of NLPs (Fig. 3A). NLP height and full width at half
maximum (FWHM) diameter was determined through cross-sectional
analysis as demonstrated in Fig. 3B. Height and diameter data was
used to establish height versus diameter scatter plots of NLPs
assembled in both the presence (bR-NLP assembly) and absence
(empty NLP assembly) of bR (Fig. 3C). These scatter plots show two
discernible populations of NLPs in the br-NLP assembly, those with
heights that are consistent with NLP heights from an empty-NLP
reaction and a population of particles with heights that signiﬁcantly
exceed those of empty particles. Empty NLPs had an average height of
4.5 nm corresponding closely to empty-NLP heights measured
previously [6,21] and to known DMPC phospholipid bilayer thickness
[25,26]. The particles with increased height in the br-NLP assemblyresis of bR-NLPs and empty-NLPs. (B) Tricine denaturing gel 16% SDS PAGE for an empty-
nding to bR and apoE422k. (C) Native gel electrophoresis of 3 SEC fractions spanning the
here green indicates cy3-E422k, red indicates cy2-bR and the yellow is the co-localization
stain of the gel. (D) Tricine denaturing gel 16% SDS PAGE of Cy2-bR, Cy3-apoE422k and 3
y3-apoE422k. The Cy3/Cy2 bR-NLPs contained two bands; a red band and green band
owing 550.7 nm and 556.0 nm absorbance maxima for dark adapted bR-NLPs and light
engths (not shown).
Fig. 3. AFM (A) AFM image of NLPs from a bR assembly showing particles with and without bR association (inset zoomwith 20 nm scale bar). (B) Cross-sectional height of particles.
Cross-section is indicated by the yellow dotted line in the image inset. Arrows indicate the direction of the cross-section. (C) Scatter plots showing individual particle height and
FWHM diameter for both an empty assembly with no bR added, and an assembly with bR. (D) Average height and standard deviation calculated from scatter plots in C.
Fig. 4. Data showing biotinylated-bR NLPs binding to streptavidin (SA). (A–D) shows
microarray binding data for Cy5 labeled SA binding to the following reagents: A)
positive control, biotinylated bR, (B) negative control, non-biotinylated bR, (C) biotin bR-
NLPs, and (D) empty-NLPs. (E) AFM image of biotin-bR NLPs incubated with SA, then
immobilized on mica substrate. White color represents height of 7–10 nm. (F) Height
section plot of path outlined by the yellow dotted line in the image. Arrows indicate the
direction of the cross-section.
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over those of empty NLPs. Such heights correspond to the height
difference determined for bR embedded in liposomes by AFM [27] and
is consistent with dimensions and spatial orientation observed in the
bR crystal structure [28].
From this analysis, particles with heights greater than two
standard deviations above the average height of NLPs assembled in
the absence of bR were designated by blue dots in Fig. 3C, while those
with height values below this cutoff were designated by black dots in
Fig. 3C. Fig. 3D summarizes the height change observed when
comparing br-NLPs to empty-NLPs. Increases in height were consis-
tent with bR association and insertion into the NLPswith overall yields
corresponding to 50–70% bR-NLPs.
Protein microarrays were used to verify successful biotinylation of
bR through binding of Cy5-labeled streptavidin to biotinylated bR and
biotinylated br-NLPs (Fig. 4A–D). Fluorescence scanning of the protein
arrays showed a 4.7 fold increase in ﬂuorescence with biotinylated bR
(p-value of 2.37×10−05) relative to the non-biotinylated control,
compared to a 5.6 fold increase for bR-NLPs (p-value of 6.29×10−12)
relative to the non biotinylated control indicating proper biotinylation
of bR.
AFM imaging and height analysis of the biotin br-NLP assembly
before streptavidin (SA) addition, revealed a bimodal height distribu-
tion (centered at 4.4±0.3 nm and 5.4±0.3 nm) as described above.
After streptavidin addition a notable increase in height was observed
for a sub-population of particles indicating that SA bound selectively
to biotin-br-NLPs. A representative image and cross-section is shown
in Fig. 4E–F. Several particles, identiﬁed by white pseudo color, were
greater than 6 nm in height clearly identifying topographic enhance-
ment of the particles. The cross-sectional line trace in Fig. 4F shows
particle heights ranging from 4.2 nm to 9.8 nm. A histogram analysis
of several hundred NLP heights revealed that the peak corresponding
to a height centered at 5.4 nm before SA addition was markedly
reduced following SA addition and replaced with a population of
particles of increased heights (Table 1). These taller particles had a
broad height distribution spanning 6.2 nm to 11 nm, consistent with
subunit or tetrameric streptavidin bound to biotinlyated br-NLPs [29].Non-biotinylated br-NLPs showed no signiﬁcant increase in overall
height with SA addition (Table 1). It is worth noting that we observed a
relative increase in the fraction of empty-NLPs (i.e. NLPs with heights
between 4.0 and 5.0 nm) after SA incubation. We currently do not
knowwhy this occurred but it may have been due to the spin ﬁltration
Table 1
Particle height data for biotin-bR NLPs and bR-NLPs before and after the incubation of
SA
Condition 4.0–5.0 nm 5.0–6.0 nm N6.0 nm
Biotin bR-NLP/ −SA 0.46 0.54 0
Biotin bR-NLP/ +SA 0.61 0.05 0.34
bR-NLP/ −SA 0.45 0.53 0.02
bR-NLP/ +SA 0.61 0.39 0
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separate NLPs from unbound SA. Therefore, it is possible that some
material was lost during this process, which may account for the
relative increase in the population of empty-NLPs. Despite this
discrepancy, after SA addition almost no NLPs displayed a height
between 5.0 and 6.0 nm, which support the notion that the NLPs with
5.0–6.0 nm heights represented bR containing NLPs.
Diameters determined by AFM for NLPs assembled both in the
presence and absence of bR did not vary around a single mean but
rather varied slightly around several discrete and stable means (Fig.
5A). The existence of discrete NLP diameters is consistent with our
previous report where NLP size distributions were quantiﬁed [21]. The
diameter histogram determined by AFM clearly indicates that the
diameter distribution shifts to larger particle sizes for NLPs assembled
in the presence of bR (Fig. 5A). To verify the observed shift in the
diameter distribution for particles assembled in the presence of bR,
particle sizes were also analyzed by ion mobility spectrometry (IMS).
The IMS traces conﬁrms that the diameter distribution is shifted to
larger particles for NLPs assembled in the presence of bR (black line)
relative to empty NLP assemblies (gray line) (Inset, Fig. 5A). NLPs from
the control assembly (not containing bR) (Fig. 5A— gray line) and NLPs
from bR-NLP assemblies whose height was similar to that of NLPs
assembled in the absence of bR (Fig. 5B— black line) were more likely
to have diameter values of 18 nm and smaller. However, NLPs from theFig. 5. (A) Histogram of NLP diameter determined through AFM for the bR assembly (black
distribution for the bR assembly (black line) and empty control assembly (gray line). (B) DiambR-NLP assemblies whose height is 1 nm larger than that of NLPs
assembled in the absence of bR are more likely to have diameters of
18 nm and larger (Fig. 5B — blue line).
4. Discussion
AFM has previously been used to accurately discriminate two
subpopulations of particles [30–32]. In this study, AFM was used as a
single particle imaging technique and a signiﬁcant increase in height
for a relatively large fraction of NLPs assembled with bR was observed.
Since empty NLPs rarely attain heights above 5 nm we hypothesize
that the larger height values in the bR assembly resulted from an
incorporated bR. If we assume the height distribution of br-NLPs and
empty-NLPs within the same sample are described by two Gaussian
distributions, we ﬁnd the ﬁrst is centered at 4.6 nm±0.3 nm and the
second centered at 5.4 nm±0.4 nm. These two population peaks are
separated by 0.8 nm, which corresponds closely to the height
differential of a bR molecule [27] and the phospholipid bilayer [26].
To further verify identiﬁcation of successful bR incorporation we
assembled NLPs in the presence of biotinylated bR. Biotinylation of bR
and the association of biotin-bR with NLPs were conﬁrmed by
visualizing binding of Cyanine 5 (Cy5) labeled streptavidin in protein
microarrays. It was also shown that streptavidin did not signiﬁcantly
bind to empty-NLPs prepared in the absence of bR. Because our
microarray data could not distinguish between br-NLPs and empty-
NLPs within the same sample, we utilized streptavidin binding as a
molecular contrast agent to selectively identify individual br-NLPs.
This is equivalent to improving image contrast in optical microscopy
by adding a dye contrast agent. Similar approaches have been used
previously in AFM imaging [32]. By binding streptavidin, the
topographic height differential between br-NLPs and empty NLPs
within a given sample increased from less than 1 nm to over 2.5 nm.
This method for identifying membrane proteins within NLPs isline) and empty control assembly (gray line). Inset — IMS traces of particle diameter
eter distributions for bR-NLPs (blue line) and empty NLPs (black line) in the bR assembly.
Table 2
The fraction of NLPs containing bR for a given NLP size
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and binding of streptavidin or by using antibodies speciﬁc to the
membrane protein. Through this combined approach we were able to
determine that approximately 60% of the NLPs contained bR under
these assembly conditions.
The ability to identify whether individual particles incorporate bR
allowed us to correlate NLP diameter and bR incorporation. The
empty- and br-containing NLPs show diameters with discrete and
stable diameters [21], with the caveat being that the br-NLP diameter
distributions were shifted to larger values relative to empty-NLPs (Fig.
5A and B) The empty-NLP distribution in the samples assembled in the
presence and absence of bR was skewed toward the smallest diameter
NLP (14 nm). In contrast, the proportion of the smallest diameter
particles in bR-NLPS signiﬁcantly reduced and the proportion of larger
particles at 18 nm, 23 nm, and 28 nm greatly increased. Not only were
br-NLPs larger on average than the empty-NLPs, but the presence of bR
during self-assembly appears to drive the formation of larger diameter
particles (Fig. 5A). It is worth noting that molecular modeling and
simulations suggest that the discrete stable diameters observed here
are consistent with discrete numbers of apolipoprotein scaffolding
stabilizing the circumference of different particle sizes.
To quantify this effect, the fraction of bR containing NLPs was
calculated for each discrete size. This value was calculated as the ratio
of br-NLPs to the sum of NLPs within a diameter range determined
from the peaks of Fig. 5B. These values as a function of particle
diameter are listed in Table 2. The incorporation probability correlated
closely with particle diameter; it was lowest for the smallest particles
from peak 1 (less than 26%) and increased to 100% for particles larger
than 30 nm.
It is not clear why the presence of bR results in the formation of
larger particles. The likely form of incorporated bR was a monomer
(22 kDa) or trimer (66 kDa) depending upon the lipid:bR stoichio-
metry [16]. Spectral results from the light/dark adaptation show
absorption maxima (550.7 nm/556.0 nm) that are in between that of
detergent solubilized monomeric (546 nm/553 nm) and trimeric
(560 nm/568 nm) bR, respectively [24]. The larger trimer with
associated archaeal lipid has a crossectional area of 3380 A2 in the
plane of the lipid bilayer [33] and has a diameter that is less than 8 nm
[34] and thus should readily ﬁt into 14 nm particles. That this rarely
occurs can perhaps be explained by the fact that physiological lipids
surrounding the bR may be carried through the puriﬁcation and
assembly process by tight binding [28] or that the some amount of
DMPC lipid is utilized in the self assembly. Alternatively, bR-NLPs may
contain bR oligomers that are larger than a trimer.
Our results show that the membrane protein bR was not
incorporated into every NLP. However, the incorporation probability
may be improved by assembling the NLP under conditions that favor
the formation of larger particles. Previous investigations have
measured bR-NLPs with a truncated apoA scaffold to be 9.2 nm in
diameter as determined by calibrated size exclusion chromatography
[17]. However, this method measures an average of all species in a
mixture; thus it is not suitable for observing multiple particle sizes. In
fact, heterogeneous particles were observed by TEM imaging,
however the authors of this study did not focus on NLP size
distribution [17]. Furthermore, the efﬁciency of bR incorporation
was not quantiﬁed so it is possible that the majority of particles
displaying bR activity were larger than the reported 9.2 nm. In fact byusing larger scaffold proteins and smaller lipid to bR ratios, Bayburt et
al. recently showed that larger particles contain a higher fraction of
trimer versus monomer bR species [16], which may also reﬂect higher
efﬁciencies of bR incorporation. It is also worth noting that NLPs were
assembled with DMPC, which is not a typical lipid found in cellular
membranes. Therefore, it is plausible that the use of native lipids for
NLP assembly may increase the membrane protein incorporation
efﬁciency, since the native lipid–membrane protein interactions may
be more favorable than DMPC–membrane protein interactions. Based
on this notion, it would be valuable to examine the effects of the lipid
component on membrane protein incorporation efﬁciencies, particu-
larly when this technology is utilized for the solubilization of a wider
range of membrane proteins.
We have demonstrated methods to quantify NLP membrane
protein incorporation efﬁciencies and have shown that the levels of
incorporation varywith NLP size. Themost signiﬁcant and novel result
was that larger particles had a greater likelihood of containing bR than
smaller particles. These results may prove valuable for future
strategies in designing protocols for membrane protein incorporation.
It has been shown that the size of empty NLPs can be controlled by the
use of different sized scaffolds or by changing the ratios of protein to
lipid [18,35]. Therefore, future strategies may involve engineering
scaffold proteins to form larger particles in combinationwith utilizing
protein to lipid ratios that drive the NLP assembly process to larger
particles.
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